provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
Eylea Coupon - Eylea 0.05ml of 2mg/0.05ml vial

Eylea

aflibercept
Used for Macular Degeneration
Used for Macular Degeneration

Eylea (aflibercept) is used for certain eye conditions related to the retina (a layer of cells in the back of the eye) for both adults and premature babies. It's typically injected into the eye by an eye specialist. Eylea (aflibercept) is only available at specialty pharmacies or distributors, so a provider will help you set that up.

Last reviewed on March 19, 2023
basics-icon

What is Eylea (aflibercept)?

What is Eylea (aflibercept) used for?

  • Wet age-related macular degeneration (wet AMD)

  • Macular edema following retinal vein occlusion (MEfRVO)

  • Diabetic retinopathy (DR)

  • Diabetic macular edema (DME)

  • Retinopathy of prematurity (ROP)

How Eylea (aflibercept) works

Eylea (aflibercept) is a vascular endothelial growth factor (VEGF) inhibitor. It blocks VEGF, a protein that makes new blood vessels in the body. When there's too much of these proteins in the eye, it creates new, weak blood vessels which leak fluid into the back of the eye.

By blocking VEGF proteins from working, Eylea (aflibercept) slows the growth of additional blood vessels to lessen the amount of fluid leaking in the eye. So it helps to lower the risk of vision loss in different eye conditions.

Are you looking for information on Zaltrap (ziv-aflibercept) instead?

Drug Facts

Common BrandsEylea
Drug ClassVEGF inhibitor
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only
basics-icon

What are the side effects of Eylea (aflibercept)?

The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common Side Effects

Adults
  • Blood spots on the whites of eye (12-31%)
  • Cataract (Up to 19%)
  • Eye pain (9-13%)
  • Raised eye pressure (2-9%)
  • Greater amount of eye floaters (1-8%)
Children
  • Blood spots on the whites of the eye (5-9%)
  • Retinal detachment (5-6%)
  • Raised eye pressure (0-4%)

Other Side Effects

  • Eye redness and swelling
  • Injection site pain or bleeding
  • Feels like something is in the eye
  • Watery eyes
  • Blurry vision
  • Eyelid swelling
  • Sudden loss of vision

Serious Side Effects

Contact your healthcare provider immediately if you experience any of the following.
  • Eye infection (endophthalmitis): eye pain, sensitivity to light, loss of vision, eye redness
  • Separation of the retina from the back of the eye (retinal detachment): flashing lights, feeling like something is covering your vision, changes in your vision, or vision loss, seeing floaters

Source: DailyMed

The following side effects have also been reported

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur:

More common

Blindness

bloody eye

blurred vision

eye or eyelid redness

eye pain

seeing flashes, sparks of light, or a veil or curtain

seeing floating spots before the eyes

vision changes

Less common

Bleeding or pain at the injection site

swelling of the eyelid

Rare

Fast heartbeat

fever

headache

hives, itching, rash, or skin redness

hoarseness

irritation

joint pain, stiffness, or swelling

swelling of the eye, face, lips, hands, or feet

tightness in the chest

troubled breathing or swallowing

Incidence not known

Pain in the chest, groin, or legs, especially the calves

severe, sudden headache

slurred speech

sudden loss of coordination

sudden, severe weakness or numbness in the arm or leg

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

Feeling like something is in the eye

watery eyes

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

pros-and-cons

Pros and cons of Eylea (aflibercept)

thumbs-up

Pros

Can help with multiple eye conditions related to the retina

Typically needs to be injected once every 1 to 2 months for adults, so it's convenient for people with a busy schedule

Offers another treatment option for babies with ROP aside from laser treatment

thumbs-down

Cons

Not a safe option for people with history of blood clots (e.g., stroke, heart attack)

Injection into the eye can lead to greater risk of eye infection or injury

Might not be a safe option for people with uncontrolled high eye pressure (e.g., glaucoma)

pharmacist-tips

Pharmacist tips for Eylea (aflibercept)

pharmacist
  • You will typically receive Eylea (aflibercept) at the eye specialist's office. This medication needs to be given by a healthcare provider with the right tools and technique to lower the risk of eye infection.

    • It's best to get your Eylea (aflibercept) injection regularly according to your provider's treatment plan. If you missed an injection, talk with your provider right away about rescheduling your appointment.

      • Before receiving Eylea (aflibercept), the provider will give you a numbing medication to ease the pain and discomfort from the procedure. They will also give a topical antibiotic to prevent infection beforehand.

        • Plan for some extra time after the appointment, the provider will need to check your eye pressure after the procedure. This is because Eylea (aflibercept) can temporarily raise the eye pressure. By getting eye pressure checked, your provider can continue to make sure this medication is safe to use.

          • Consider wearing sunglasses after your Eylea (aflibercept) injection since your eyes might be more sensitive to light.

            • Don't drive a car or operate machinery until you know how Eylea (aflibercept) affects you because it can cause temporary visual changes. Instead, arrange for someone to drive you to and from your eye appointment.

              • Because certain eye problems can get worse over time, it's important that you check your vision in between Eylea (aflibercept) injections. Your provider should discuss with you the best way to monitor your vision.

                • Tell the provider right away if you experiences eye pain, eye redness, blurry vision, or sensitivity to bright light after receiving Eylea (aflibercept). This is because it can sometimes cause severe eye problems, such as serious eye infection or damage.

                  • Children who receive Eylea (aflibercept) for ROP might need more than one injection of this medication, as well as regular monitoring of eye symptoms. This is because abnormal blood vessels can grow in the retina even after treatment with Eylea (aflibercept), which can worsen ROP.

                    faqs

                    Frequently asked questions about Eylea (aflibercept)

                    How well does Eylea (aflibercept) work for wet age-related macular degeneration (wet AMD)?
                    Studies showed that Eylea (aflibercept) helps people with wet AMD see nearly two more rows of letters on an eye chart. This medication has also helped 94% of people in clinical studies with wet AMD maintain their vision for more than a year. If you have any questions about whether Eylea (aflibercept) is right for you, follow up with your provider for more information.
                    Is Eylea (aflibercept) a cure for diabetic retinopathy (DR)?
                    No, Eylea (aflibercept) isn't a cure for DR. Currently, all available treatments or medications for DR can only slow down or stop your vision from getting worse. Eylea (aflibercept) can slow down the progression of DR. In one study, about 80% of people who received Eylea (aflibercept) for a year had less serious DR compared to only 15% of people who didn't receive this medication. Ask your provider if you have more questions about DR and its treatment.
                    What's the difference between Eylea (aflibercept) and other similar eye injections for wet AMD?
                    Eylea (aflibercept) and similar medications like Beovu (brolucizumab), Lucentis (ranibizumab), and Avastin (bevacizumab) are all used to treat wet AMD. They are all VEGF inhibitors, meaning they work similarly. Avastin (bevacizumab) was originally approved to treat cancer, but many eye specialists are using it off-label to treat wet AMD. Although there are slight differences in how often you receive the medication, there aren't that many differences between them. You just might respond better to one medication versus another. Talk with your provider to determine which medication is best for you.
                    Can I get Eylea (aflibercept) if I have had a heart attack or stroke?
                    Maybe. Studies showed that some people with eye problems that got Eylea (aflibercept) developed blood clot problems, including heart attack and stroke. While the risk is low, it's important to look out for life-threatening side effects related to blood clots. Get medical attention right away if you have symptoms of a stroke (sudden confusion, severe headache, facial drooping, weakness on one side of the body, slurred speech, or trouble walking) or a heart attack (chest pain that travels to your arm or jaw, sweating, or shortness of breath). Discuss with your provider the risks versus benefits of using this medication if you've had a history of heart attack or stroke.
                    Can I get Eylea (aflibercept) if I'm pregnant?
                    Eylea (aflibercept) hasn’t been studied in pregnant people, but animal studies showed that this medication caused birth defects in baby animals. If you're female who can get pregnant, make sure to use birth control, like condoms, before the first injection of Eylea (aflibercept), during treatment, and for at least 3 months after you stop. If you’re pregnant or planning on becoming pregnant, talk to your provider so you can discuss the risks of receiving Eylea (aflibercept).
                    GoodRxEducationalIcon

                    How to save using GoodRx

                    Compare Prices
                    1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
                    Select your free coupon
                    2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
                    Show coupon to your pharmacist
                    3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
                    Get free couponLearn more
                    warings-icon

                    What are the risks and warnings for Eylea (aflibercept)?

                    Eylea (aflibercept) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.

                    risk-warning

                    Eye infection and damage

                    Very rarely, eye injections, such as Eylea (aflibercept), can lead to endophthalmitis (infection of the tissues or fluids inside the eyeball) or detached retina (when the retina pulls away from the back of the eye). This can sometimes happen when the eye gets contaminated or infected during the injection. Your or your child's healthcare provider might provide a topical antibiotic beforehand to lower the risk of infection. They will also have the proper techniques and tools to lower the risk of contamination during the procedure. Make sure to follow up with the provider after your or your child's appointment to monitor for any visual changes. If your or your child's eye becomes red, sensitive to light, painful, or develops a change in vision, let the provider know right away.

                    risk-warning

                    Higher eye pressure

                    • Risk factor: Regular injections of Eylea (aflibercept)

                      People who receive Eylea (aflibercept) can sometimes experience higher eye pressure because there's more fluid in the eye due to the injection. This is usually temporary and typically happens within an hour after the injection. The risk is higher in people who get regular eye injections. You or your child will need to get eye pressure checked each time after receiving Eylea (aflibercept) so the provider can make sure this medication continues to be safe. If you or your child experiences intense eye pain, nausea, red eye, and blurry vision after receiving Eylea (aflibercept), talk with the provider immediately.

                      risk-warning

                      Heart attack or stroke

                      • Risk factor: History of heart attack or stroke

                        Eylea (aflibercept) injections might cause serious blood clot problems, such as heart attack and stroke. Symptoms of a stroke include sudden confusion, severe headache, facial drooping, weakness on one side of the body, slurred speech, or trouble walking. Symptoms of a heart attack include chest pain that travels to your arm or jaw, sweating, or shortness of breath. If you have symptoms of a stroke or heart attack, get medical help right away.

                        dosage

                        Eylea (aflibercept) dosage forms

                        Typical dosing for Eylea (aflibercept)

                        The dose of Eylea (aflibercept) depends on the condition being treated. In general:

                        Adults

                        • Wet AMD: The typical starting dose is 2 mg into the eye(s) once a month for 3 months. Afterwards, 2 mg once into the eye(s) every 2 months.

                        • MEfRVO: The typical dose is 2 mg into the eye(s) once a month (about every 25 days).

                        • DR and DME: The typical starting dose is 2 mg into the eye(s) once a month for the first 5 months. Afterwards, 2 mg once into the eye(s) every 2 months.

                        Children

                        • ROP: The typical dose is one 0.4 mg injection into the eye(s). And if needed, your child might receive another injection 10 days after the first injection.

                        interactions

                        Interactions between Eylea (aflibercept) and other drugs

                        Eylea (aflibercept) may interact with certain medications or supplements. Always let your doctor and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking. The list below does not include all possible drug interactions with Eylea (aflibercept). Please note that only the generic name of each medication is listed below.

                        Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

                        contraindications-icon

                        Eylea (aflibercept) contraindications

                        Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Eylea (aflibercept) will not be safe for you to take.
                        • Infection in or around the eye

                        • Active eye inflammation (e.g., swelling, pain, redness)

                        alternatives

                        What are alternatives to Eylea (aflibercept)?

                        There are a number of medications that your doctor can prescribe in place of Eylea (aflibercept). Compare a few possible alternatives below.
                        Eylea (aflibercept)
                        Used for:
                        • Wet age-related macular degeneration (wet AMD)

                        • Macular edema following retinal vein occlusion (MEfRVO)

                        • Diabetic retinopathy (DR)

                        • Diabetic macular edema (DME)

                        • Retinopathy of prematurity (ROP)

                        Used for:
                        • Treatment of wet age-related macular degeneration (wet AMD)

                        Used for:
                        • Neovascular (wet) age-related macular degeneration (AMD)

                        • Macular edema following retinal vein occlusion (RVO)

                        • Myopic choroidal neovascularization (mCNV)

                        • Diabetic macular edema (DME)

                        • Diabetic retinopathy (DR)

                        latest news

                        What is the latest news about Eylea (aflibercept)?

                        images

                        Eylea (aflibercept) images

                        yellow - EYLEA 2mg / 0.05mL Solution for Injection
                        This medicine is Yellow Vial.yellow - EYLEA 2mg / 0.05mL Solution for Injection

                        Get savings updates for Eylea (aflibercept)

                        Receive price alerts, news, and other messages from GoodRx about Eylea (aflibercept) and other healthcare topics and relevant savings offers.

                        By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

                        References

                        Best studies we found

                        American Society of Retina Specialists. (n.d.). Age-related macular degeneration.

                        Boyd, K. (2023). What is macular degeneration? American Academy of Ophthalmology.

                        Centers for Disease Control and Prevention. (2022). Stroke signs and symptoms.

                        View All References (14)

                        MedlinePlus. (2016). Retinal disorders.

                        Moraru, A., et al. (2017). Incidence of ocular hypertension after intravitreal injection of anti-VEGF agents in the treatment of neovascular AMD. Romanian Journal of Ophthalmology.

                        Mukamal, R. (2020). Comparison of anti-VEGF treatments for wet AMD. American Academy of Ophthalmology.

                        Mukamal, R., et al. (2023). What is endophthalmitis? American Academy of Ophthalmology.

                        National Eye Institute. (2023). Retinal detachment.

                        National Eye Institute. (2023). Retinopathy of prematurity.

                        Penn, J. S., et al. (2008). Vascular endothelial growth factor in eye disease. Progress in Retinal and Eye Research

                        Regeneron Pharmaceuticals, Inc. (n.d.). About eye conditions that affect the retina.

                        Regeneron Pharmaceuticals, Inc. (n.d.). Appointment & treatment tips.

                        Regeneron Pharmaceuticals, Inc. (n.d.). Eylea helps prevent the progression of diabetic retinopathy.

                        Regeneron Pharmaceuticals, Inc. (n.d.). If you have wet AMD—Take control of your sight with Eylea.

                        Regeneron Pharmaceuticals, Inc. (2020). Amsler grid.

                        Regeneron Pharmaceuticals, Inc. (2023). Eylea- aflibercept injection, solution [package insert]. DailyMed.

                        Sachdeva, M. M., et al. (2016). Endophthalmitis following intravitreal injection of anti-VEGF agents: long-term outcomes and the identification of unusual micro-organisms. The Journal of Ophthalmic Inflammation and Infection.

                        GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.
                        Was this page helpful?

                        Browse medications

                        View All

                        Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.